Since the discovery of interleukin-8, about 50 chemokines have been identif
ied and characterized, Originally, they were considered as inducible mediat
ors of inflammation, but in recent years, several chemokines were identifie
d that are expressed constitutively aid function in physiological traffic a
nd homing of leukocyte-lymphocytes in particular. All chemokines act via se
ven-transmembrane domain, G protein-coupled receptors, Eighteen such recept
ors have been identified so far. Studies on structure-activity relationship
s indicate that chemokines have two main sites of interaction with their re
ceptors, the flexible NH2-terminal region and the conformationally rigid lo
op that follows the second cysteine. Chemokines are thought to dock onto re
ceptors by means of the loop region, and this contact is believed to facili
tate the binding of the NH2-terminal region that results in receptor activa
tion. These studies have also highlighted the importance of the NH2-termina
l region for agonistic and antagonistic activity. Recently, we have shown t
hat some naturally occurring chemokines can function as receptor antagonist
s. These observations suggest a new mechanism for the regulation of leukocy
te recruitment during inflammatory and immune reactions, which are based on
the combination of agonistic and antagonistic effects.